Bavarian Nordic A/S announced that the European Health Emergency Preparedness and Response Authority (HERA) has ordered an additional 170,000 doses of MVA-BN smallpox/monkeypox vaccine, which will be made available to EU Member States, Norway and Iceland. With deliveries scheduled before year-end, the new order will double the supply of monkeypox vaccines to HERA in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.8 DKK | +2.73% | +4.65% | -9.92% |
04-30 | Bavarian Nordic Books EUR65 Million Order for Smallpox Vaccine | MT |
04-29 | Bavarian Nordic A/S Receives EUR 65 Million Contract to Supply Smallpox Vaccines for EU Strategic Reserve | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.92% | 1.75B | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic A/S Enters Additional Monkeypox Vaccine Supply Contract with the European Health Emergency Preparedness and Response Authority